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Abstract Due to their advantageous characteristics, gold
nanoparticles (AuNPs) are being increasingly utilized in a
vast array of biomedical applications. However, the effi-
cacy of these procedures are highly dependent upon strong
interactions between AuNPs and the surrounding environ-
ment. While the field of nanotechnology has grown expo-
nentially, there is still much to be discovered with regards
to the complex interactions between NPs and biological
systems. One area of particular interest is the generation of
a protein corona, which instantaneously forms when NPs
encounter a protein-rich environment. Currently, the cor-
ona is viewed as an obstacle and has been identified as the
cause for loss of application efficiency in physiological
systems. To date, however, no study has explored if the
protein corona could be designed and advantageously uti-
lized to improve both NP behavior and application efficacy.
Therefore, we sought to identify if the formation of a
preliminary protein corona could modify both AuNP
characteristics and association with the HaCaT cell model.
In this study, a corona comprised solely of epidermal
growth factor (EGF) was successfully formed around
10-nm AuNPs. These EGF-AuNPs demonstrated aug-
mented particle stability, a modified corona composition,
and increased deposition over stock AuNPs, while
remaining biocompatible. Analysis of AuNP dosimetry
was repeated under dynamic conditions, with lateral flow
significantly disrupting deposition and the nano-cellular
interface. Taken together, this study demonstrated the
plausibility and potential of utilizing the protein corona as
a means to influence NP behavior; however, fluid dynamics
remains a major challenge to progressing NP dosimetry.
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Introduction
In recent years, colloidal gold nanoparticles (AuNPs) have
attracted significant attention for use in biomedical appli-
cations. For example, research is underway to develop
AuNP-based procedures for drug and gene delivery, bio-
imaging techniques, sensor systems, cancer therapeutics,
and vaccine development (Dykman and Khlebtsov 2012;
Stacy et al. 2013). AuNPs are viewed as advantageous over
other materials for a multitude of reasons, including a
general biocompatibility, standardized synthesis protocols,
ease of functionalization, and distinctive plasmonic prop-
erties (Yeh et al. 2012). While biomedical applications
vary in function, what they have in common is the need for
a high AuNP delivery rate to be effective. Current design
efforts to improve colloid delivery and deposition have
focused on material-based approaches, specifically through
modification of particle size or surface chemistry (Ban-
nunah et al. 2014; Untener et al. 2013). While these efforts
have been met with moderate success, much work remains
to optimize NP deposition and dosimetry (Pal et al. 2015).
When nano-based biomedical applications are applied
within a biological system, there exists a significant loss of
effectiveness. Physiological variables have been shown to
modify NP properties and behavior, providing an expla-
nation for these discrepancies (Tenzer et al. 2013). For
example, when NPs are introduced to a biological system,
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surrounding proteins instantaneously adsorb onto their
surface, generating a protein corona: which serves as the
biological identify of the NPs (Gunawan et al. 2014). The
protein corona is dynamic by nature with its composition
dependent on numerous factors, including localized protein
gradients, available biomolecules, kinetic equilibrium
constants, and circulation time (Sahneh et al. 2015). The
corona is comprised of two distinct layers, referred to as
the hard and soft coronas. The hard corona is a single layer
of proteins directly bound to the NP surface with high
affinity, forming a stable coating. The soft corona, which
covers the hard corona, is loosely associated and, therefore,
promotes dissociation and rapid biomolecule exchange
(Winzen et al. 2015). Previous studies have demonstrated
that the protein corona directly impacts the nano-cellular
interface, thereby determining NP deposition efficiency,
membrane interactions, degree of endocytosis, and bio-
compatibility (Chanana et al. 2013; Lesniak et al. 2013;
Treuel et al. 2014).
The protein corona has been identified as the primary
source for loss of application efficacy and poor predicative
modeling in complex biological systems (Salvati et al.
2013). To date, the nonspecific adsorption involved with
the protein corona is typically viewed as a negative and
unavoidable side effect (Hamad-Schifferli 2013). In addi-
tion to modifying the surface area to volume ratio and the
nano-cellular interface, a protein–NP complex increases
aggregation and introduces a level of unpredictability
through the weak chemical bonds supporting this structure.
While the scientific community has agreed that protein
coronas are an inevitable aspect of nano-biotechnology, it
has yet to be explored if generating a targeted protein
corona prior to biological introduction is of benefit with
regards to NP stability, dosimetry, or subsequent
bioresponses.
Additionally, in vivo systems are circulatory and
dynamic resulting in tissue-based biotransport. As standard
in vitro models operate under static conditions, fluid
dynamic variations to NP and cellular behavior are
neglected in these models. Preliminary work has identified
that the introduction of dynamic flow modified cellular
morphology, NP behavior, and NP dosimetry (Breitner
et al. 2015; Kusunose et al. 2013; Ucciferri et al. 2014).
These results suggest that the nano-cellular interface and
the rate of NP deposition will be influenced by dynamic
flow; making it a critical variable to include during AuNP
application analysis.
As such, the goal of this study was to explore if AuNP
behavior and deposition efficiency could be improved
through the targeted generation of a preliminary protein
corona. Using 10-nm AuNPs, a protein corona comprised
solely of epidermal growth factor (EGF) was formed prior
to cellular exposure (EGF-AuNPs). EGF was chosen due to
the fact that its receptor is predominantly expressed on
most cell types, providing an opportunity for increased
AuNP–cellular binding. The human keratinocyte HaCaT
cell line was selected owing to its role as a model system
for NP evaluations (Comfort et al. 2014a) and its docu-
mented expression of EGF receptors (Chichocki et al.
2014). Our results demonstrated altered behavior of the
EGF-AuNPs versus untreated AuNPs, including stabiliza-
tion of agglomerates, a larger protein corona size, and
increased deposition. In an attempt to better predict AuNP
delivery under realistic conditions, deposition analysis was
repeated under dynamic conditions. The introduction of
fluid flow altered the modes of biotransport, limiting
AuNP–HaCaT interactions and reducing AuNP deposition.
Taken together, these results revealed that targeted protein
corona formation is capable of stabilizing AuNP behavior
and improving delivery rate. However, for this process to
be effectively incorporated into the design of nano-based
applications, other factors, such as the presence of dynamic
flow, need to be accounted for.
Experimental section
NP characterization
The 10-nm, citrate-coated AuNPs were purchased in con-
centrated solution form from Nanocomposix. Prior to cell
exposure, the AuNPs were characterized to identify target
physicochemical parameters. Transmission electron
microscopy (TEM) imaging was carried out on a Hitachi
H-7600. Dynamic light scattering (DLS) and zeta potential
analyses were performed on a Malvern Zetasizer Nano-ZS.
The spectral signature of the AuNPs was identified through
UV–VIS analysis on a Varian Cary 5000. Characterization
was carried out in accordance with manufacturer specifi-
cations at a concentration of 25 lg/mL.
Cell culture
The human keratinocyte cell line, HaCaT, was a kind gift
from the Air Force Research Laboratories. HaCaTs were
maintained in RPMI 1640 medium supplemented with
10 % fetal bovine serum (FBS) and 1 % penicillin/strep-
tomycin at 37 C in a humidified incubator. During
experimentation, HaCaTs were seeded in 24-well plates at
a concentration of 2 9 105 cells per well. All cell culture
supplies were purchased from Life Technologies.
Establishment of a dynamic cellular system
Dynamic flow was introduced through the use of a
24-channel peristaltic pump (Ismatec), with each channel
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connected to a single cell culture well. The pump operated
with standard 1/16 inch tubing, positioned at opposite ends
of each well to ensure unidirectional flow. The pump was
ran at a target volumetric flowrate of 1.98 9 10-2 cm3/s to
produce average linear velocities of 1.0 and 0.01 cm/s in
the tubing and across the cell surface, respectively. This
flowrate was chosen to match known physiological flow
patterns. To minimize the introduction of environmental
variables, the entire pump system was housed within the
incubator.
Protein corona establishment
FBS within the media served as the protein source to form
the corona. To ensure consistency, the same FBS lot was
used throughout this study. The EGF-AuNPs were formed
by incubating 15 lg/mL AuNPs in excess (10 lM) solu-
tion of human recombinant EGF (Peprotech) at 4 C. After
48 h, the EGF-coated AuNPs were recovered through
centrifugation, resuspended, and either characterized or
introduced to the HaCaT cells.
Protein corona identification and quantification
Following incubation of either AuNPs or EGF-AuNPs in
water or media (total mass of 15 lg), the AuNPs were
pelleted through centrifugation. The NPs were washed
twice with phosphate-buffered saline (PBS) to remove any
unattached protein, and were resuspended in 30 lL PBS.
The proteins were removed from the AuNP surface by
boiling for 5 min in 29 Laemmli sample buffer (Biorad),
after which the NPs were again pelleted. Following
removal from the AuNPs, the protein concentration was
determined using DC Protein Assay (Biorad), in accor-
dance with the manufacturer’s instructions.
The protein corona was visualized through SDS-PAGE
analysis. Briefly, the protein-containing supernatant was
loaded onto a 4–20 % gradient mini-PROTEAN TGX gel
(Biorad). Following electrophoresis, the gel was rinsed in
water and dyed with Gel Code Blue (Life Technologies)
for band visualization.
AuNP deposition efficiency
HaCaTs were seeded in a 24-well plate at a density of
2 9 105 cells per well and returned to the incubator
overnight to ensure full adherence. Fresh dosing solutions
at a concentration of 15 lg/mL of either AuNPs or EGF-
AuNPs were generated and underwent UV–VIS analysis.
The cells were then washed and dosed with the denoted NP
set and incubated under either static or dynamic conditions
for 24 h. Fluid samples were collected in triplicate and
analyzed via UV–VIS to determine the final AuNP
concentration (Zook et al. 2011). The change in AuNP
concentration was considered the deposited dose.
HaCaT viability assessment
HaCaT cells were seeded in 24-well plates at a density of
2 9 105 cells per well and incubated for 24 h to allow for
full adherence. Next, they were dosed with 15 lg/mL of
the denoted AuNPs for a duration of 24 h, after which cell
viability was assessed using the CellTiter 96 Aqueous One
Solution (Promega) in accordance with the manufacturer’s
specifications. HaCaTs that were untreated served as the
negative control for normalization.
Cellular internalization
For visualization of AuNP internalization, TEM imaging
was utilized. The HaCaTs were seeded in 24-well plates at
a density of 2 9 105 cells per well, returned to the incu-
bator for 24 h, then dosed with 15 lg/mL AuNPs for 24 h.
The HaCaTs were washed, detached from the plate with
trypsin, and fixed in 2 % paraformaldehyde/2 % glu-
taraldehyde. The cells were then stained with 1 % osmium
tetroxide, dehydrated with increasing ethanol concentra-
tions, and cured in 100 % LR White resin (Electron
Microscopy Sciences). The pellets were then thin-sectioned
using a Leica ultramicrotome and TEM imaged.
Visualization of the nano-cellular interface
The nano-cellular interface was imaged using a combina-
tion of high-resolution fluorescence and dark-field micro-
scopy. HaCaTs were plated into a two-chambered slide at a
concentration of 2 9 105 cells per chamber and allowed
time to fully adhere. The cells were then exposed to either
AuNPs or EGF-AuNPs under both static and dynamic
conditions for 24 h. The HaCaTs were then washed, fixed
with 4 % paraformaldehyde, permeabilized with Triton
X-100, blocked with bovine serum albumin, and stained
with DAPI and Alexa Fluor 555-phalloidin (Invitrogen) for
nuclear and actin visualization. The HaCaT samples were
then imaged on an Olympus BX41 microscope (fluores-
cence) with a CytoViva attachment (dark field) for AuNP
visualization (Aetos Technologies).
Statistical analysis
All data are expressed as the mean ± the standard error of
the mean. For NP agglomerate size analysis, a two-way
ANOVA with Bonferroni post-test was run using Graph
Pad Prism (n = 3, p\ 0.05), with * indicating significance
between fluids for the same NP set and  indicating sig-
nificance between NP sets in the same fluid. For protein
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concentration and deposition efficiency a one-way
ANOVA with Bonferroni post-test was carried out (n = 4,
p\ 0.05) with * designating statistical significance as
indicated.
Results
Gold nanoparticle selection and characterization
The nano-gold utilized in biomedical applications can span
multiple morphologies, sizes, and surface coatings; each
with their own advantages and disadvantages. While a
number of different morphologies can be synthesized,
including spheres, shells, rods, and cubes, non-spherical
shapes have been associated with increased cytotoxicity
(DeBrosse et al. 2013). With regards to size, previous
studies have shown that 10 nm or smaller particles have
greater rates of cellular internalization, as they can enter a
cell through both direct diffusion and endocytosis mecha-
nisms (Shang et al. 2014). Lastly, AuNPs naturally form a
citrate coating during synthesis, meaning no additional
functionalization is necessary, thereby allowing for ease of
corona formation. Weighing these considerations, 10-nm
spherical, citrate-coated AuNPs were the nanomaterial
selected for this proof-of-concept study.
Over its years in existence, the field of nanotechnology
has recognized that minor changes in NP physical prop-
erties substantially modifies particle behavior and cellular
response (Hussain et al. 2015). Therefore, prior to cellular
exposure the 10-nm AuNPs were fully characterized. TEM
analysis was carried out (Fig. 1a) and confirmed spherical
morphology of the NPs and was used to determine the
primary particle size of 11.2 nm. Next, the AuNP spectral
signature was identified through UV–VIS analysis, which
demonstrated a single, sharp peak at approximately 520 nm
(Fig. 1b). A peak at this wavelength is typical for colloidal
gold and the well-defined spectral profile, in addition to
TEM images, confirmed AuNP quality. As it is established
that all NPs will agglomerate to some degree in solution, an
initial agglomerate size in water was determined using
DLS (Table 1). Lastly, surface charge of the AuNPs was
identified using zeta potential, and found to be -25 mV
which is typical for citrate coatings.
Generation of the EGF corona and AuNP behavior
The next goal was to generate an EGF protein corona
around the AuNPs (EGF-AuNPs) and evaluate if these
particles behaved differently from stock AuNPs. As
exposure to the large protein source in cell media will
likely modify the protein corona and AuNP behavior,
characterization was carried out in both water and media
environments. In water, EGF-AuNPs displayed an
agglomerate size double that of untreated AuNPs; 37 nm
versus 19 nm (Fig. 2a). As the presence of a protein corona
increases the effective size, this diameter alteration indi-
cated that EGF was successfully bound to the NP surface.
Following dispersion in media, the stock AuNP
agglomerate size increased over four times versus the water
value. This AuNP agglomeration was not surprising as the
ionic content of media is known to induce NP aggregation
(Sethi et al. 2009). Interestingly, the DLS data indicated
that the EGF-AuNP agglomerate size did not vary between
water and media environments. As NPs have almost always
demonstrated increased inter-particle agglomeration fol-
lowing media exposure, these results suggest that the pre-
formed EGF corona was able to alter AuNP behavior. The
negligible change in aggregate sizing is likely due to the



















Fig. 1 a Representative TEM
image of the 10-nm AuNPs
were used to calculate a primary
particle size, verify spherical
morphology, and to guarantee
particle uniformity. b The UV–
VIS spectral profile of the
original AuNPs demonstrated
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buffer between the AuNPs and the high ionic content of the
media, thus stabilizing the particles.
Next, the spectral profiles for the original and EGF-
AuNPs were generated in both water and media (Fig. 2b).
These profiles revealed a slight right shift in the spectral
peak for EGF-AuNPs in water. This peak shift is indicative
of increased AuNP agglomerate size, in agreement with the
DLS data. Furthermore, a nearly identical alteration to the
spectral profile was seen with both particle sets in media. In
addition to the peak shift, minor broadening was identified
following media exposure; suggesting a greater degree of
agglomeration (Sethi et al. 2009). Taken together, the DLS
and UV–VIS analyses demonstrated that the EGF-AuNPs
exhibited unique behavior and physical characteristics.
To verify formation of the initial EGF corona and
evaluate final corona composition in media, SDS-PAGE
analysis was performed (Fig. 3a). In water, stock AuNPs
displayed no associated proteins (lane 1), whereas EGF-
AuNPs are associated with one predominant protein band
(lane 2); visually confirming the presence of the EGF
corona. As anticipated, AuNPs developed a large corona
comprised of numerous proteins following exposure to
media (lane 3). When examining the SDS-PAGE profile of
the EGF-AuNPs in media (lane 4), several key results are
observed. First, as FBS contains a large number of growth
factors and cytokines, most of which have similar molec-
ular weights, it is impossible to distinguish final EGF
concentration from this analysis. Additionally, the corona
Table 1 Characterization of stock 10-nm AuNPs
Primary size (nm) 11.2 ± 0.8
Agglomerate size (nm) 19.3 ± 0.4









































Fig. 2 a Agglomerate size of the AuNP sets in both water and media
was assessed using dynamic light scattering. These results demon-
strate the formation of a corona for EGF-AuNPS by the size increase
in water. Additionally, these data identified the increased stability of
the EGF-AuNPs through maintaining a constant agglomerate size
following dispersion in media (n = 3, p\ 0.05, with * and 
indicating significance between fluids for the same NP set and
between NP sets in the same fluid, respectively). b The UV–VIS
spectral profiles of both AuNP sets following dispersion in water and
media demonstrated a slight right shift and peak broadening
associated with protein addition and NP agglomeration
Fig. 3 a SDS-PAGE analysis was used to visualize the protein
corona associated with (1) AuNPs in water, (2) EGF-AuNPs in water,
(3) AuNPs in media, and (4) EGF-AuNPs in media. The presence of
predominant, single band in lane 2 verifies the formation of the EGF
corona. b The protein content associated with the protein–NP
complex was evaluated for all conditions and identified that in
media, the EGF-AuNPs contained a larger protein corona than their
untreated AuNP counterparts (n = 3, P\ 0.05, with * indicating
significance from the same AuNP condition in water)
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size substantially increased in media versus water, as
indicated through the rise in the number and intensity of
protein bands; demonstrating an environmental depen-
dency to the final protein–NP complex.
Next, the AuNP and EGF-AuNP protein coronas in
media were directly compared. Using ImageJ software, the
density of the SDS-PAGE bands was analyzed (data not
shown), and identified that the EGF-AuNP bands were
17 % denser than the stock AuNPs. To verify these results,
the protein content within the corona–NP complex was
quantified for all experimental conditions (Fig. 3b). These
results confirmed the SDS-PAGE conclusions, proving that
the EGF-AuNPs bound more protein than untreated
AuNPs. As the SDS-PAGE was loaded by equal NP
number, final protein concentration was directly propor-
tional to the corona size.
Evaluation of AuNP bioeffects and the nano-cellular
interface
Following identification that a preliminary protein corona
was able to modify both AuNP properties and the corona–
NP complex, we next explored if particle delivery and
biocompatibility were likewise impacted. As shown in
Fig. 4a, after a 24-h exposure, the deposition rate of the
EGF-AuNPs was approximately 15 % greater than the
stock AuNPs. These results were the first to identify that
the design and formation of a preliminary protein corona
could increase the rate of NP–cellular interactions. While
15 % may not appear to be a substantial increase, this
phenomena does shift the dosimetry paradigm by uncov-
ering a mechanism that allows for some control over
deposited NP dose.
Generally speaking, nano-gold is biocompatible and not
does induce significant stress or cytotoxic responses.
However, previous reports have directly correlated NP
deposition to cell viability (Kang et al. 2013). Therefore, as
the EGF-AuNPs deposited to a greater extent we assessed
whether these particles induced cell toxicity following a
24-h exposure. Even though both sets of AuNPs were
deposited to a large degree, no acute cellular death was
identified (Fig. 4b).
NPs are typically internalized through a combination of
unique endocytosis mechanisms, following membrane
association (Untener et al. 2013). As the preliminary protein
corona was comprised of EGF, we next investigated if the
possibility of augmented EGF–EGF receptor couplings
would influence AuNP internalization patterns. As seen in
Fig. 5, both the stock AuNPs (Fig. 5a) and the EGF-AuNPs
(Fig. 5b) were internalized with high efficiency; as evi-
denced through the large number of endosomes containing
particles. While no distinct differences in internalization
patterns were noted between AuNP sets, these images con-
firm that the particles were taken up through endocytosis.
Influence of dynamic flow
Next, we incorporated dynamic flow to mimic fluid
movement as seen in in vivo systems. Capillaries run
through skin tissue, thus generating a means for fluid
movement into and out of skin cells through a combination
of biological transport mechanisms. The incorporated
pump system was designed to match this behavior with
tube velocities set to capillary rates, producing flow across
the HaCaT surface orders of magnitude lower; equivalent
to diffusion and facilitated transport rates (Berger et al.
1996). Following establishment of a biologically relevant
flow system, we examined how this influence varied AuNP
deposition and the nano-cellular interface.
Under the influence of fluid flow, the deposition rate was
significantly reduced, for both stock and EGF-coated



































Fig. 4 a Under static conditions, the deposition efficiency was
quantified within an HaCaT model, with a 15 % increase seen with
EGF-AuNPs. b To ensure the biocompatibility of both AuNP sets,
HaCaT cells underwent a viability assessment following a 24-h
exposure. For both stock AuNPs and EGF-AuNPs, no cytotoxicity
was observed (n = 3, p\ 0.05, with * indicating significance
between NP sets)
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approximately 35 % of administered AuNPs. The ability of
dynamic flow to disrupt NP deposition has been previously
seen, making these results unsurprising (Breitner et al.
2015). However, the increased deposition rate seen with
EGF-AuNPs under static conditions was negated by
dynamic flow. These results suggest that while the forma-
tion of a preliminary protein corona does have the potential
to impact dosimetry, other physiological variables need to
be accounted for during the design process.
To ensure that this observed drop in deposition was not
due to HaCaT toxicity, cell viability was again assessed,
this time under dynamic flow. The viability assessment
showed a slight reduction in the number of live cells
between dynamic and static conditions (Fig. 6b), but no
significant cytotoxicity. We hypothesize that this slight
reduction is due to a slower proliferative rates instead of
cellular death, as has been previously seen (Gatonguay
et al. 2012). Additionally, these results confirmed that the
fluid movement did not negatively impact the system or
induce a synergistic response with the AuNPs.
This study demonstrated that the introduction of both a
preliminary EGF corona and dynamic flow altered the
nano-bio interface, as evidenced through NP characteriza-
tion and deposition efficiency. In an effort to better
understand our observed results, our last goal was to
visualize this interface, thereby producing a snapshot of
NP–cellular interactions. Representative images of the
nano-cellular interface for HaCaT exposure to AuNPs or
EGF-AuNPs in both static and dynamic environments are
shown in Fig. 7. Under static conditions (Fig. 7a, b),
HaCaT morphology is primarily globular with minor actin
filaments protruding. While both images demonstrate
effective NP–HaCaT association, the EGF-AuNPs appear
in larger clusters, suggesting higher rates of deposition and
internalization; in agreement with our previous data.
Under dynamic flow (Fig. 7c, d), there is a dramatic shift
in HaCaT morphology, with both the actin and nuclei elon-
gated in the directionality of flow (left to right across image
pane). These morphological alterations are not surprising,
however, given that low rates of shear stress were present in
the system. In addition to viewing changes to morphology,
these images verify HaCaT health under dynamic flow.
Taken together, the results generated in this study demon-
strate that it is possible to introduce fluid dynamics to in vitro
systems and that these variations have wide reaching impli-
cations including cell morphology and dosimetry.
Discussion
This proof-of-concept work successfully demonstrated the
plausibility of generating a protein–NP complex prior to
biological exposure in an effort to modify NP behavior and
improve delivery rate. In this study, an EGF protein corona
Fig. 5 Using TEM imaging,
AuNP internalization within the
HaCaT cell line was verified for
the (a) stock AuNPs and
(b) EGF-AuNPs. In these
images, clusters of AuNPs are
clearly identifiable within
cellular endosomes. In each


































100Fig. 6 Evaluation of (a) NP
deposition efficiency and
(b) HaCaT viability following
24-h exposure to the AuNP sets
were repeated under dynamic
flow conditions. These data sets
suggest that the presence of flow
was not harmful to the HaCaTs;
however, it did severely disrupt
AuNP biotransport mechanisms
and final deposition efficiency
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was successfully formed around 10-nm AuNPs. In addition
to its surface receptors, EGF was specifically selected
because of its documented interactions with NPs (Comfort
et al. 2014b). EGF-AuNPs displayed modified behavior
and an altered protein corona as compared to stock AuNPs;
verifying our prediction. The presence of the EGF corona
resulted in maintaining an agglomerate size of approxi-
mately 35 nm, regardless of fluid environment. As a hard
protein corona was in place, the AuNPs were protected
from the ionic media, thereby remaining more mono-dis-
perse in solution and avoiding excess agglomeration.
Moreover, the corona associated with the EGF-AuNPs was
approximately 12 % larger than the stock AuNPs. This is
likely due to their smaller agglomerate size of the EGF-
AuNPs, which produces a larger surface area to volume
ratio and allows for greater protein loading.
By pre-coating 10-nm AuNPs with EGF, particle
deposition in an HaCaT model was increased 15 % under
static conditions. While 15 % may seem minor, it is
important to recall that this was a first in kind experiment
and that these results successfully demonstrated that it was
possible to improve the deposited NP dose through design
of a protein corona. We hypothesize that this alteration to
AuNP dosimetry is due to the increased particle stability
and observed alteration to the protein corona. As smaller
agglomerates allow for increased diffusion and NP
transport, a greater fraction of AuNPs will reach the HaCaT
surface (Cho et al. 2011; Hinderliter et al. 2010); thus
increasing the deposition efficiency. This theory is further
supported by the dynamic results, which introduced a new
mode of NP transport and interfered in deposition. The
presence of lateral bulk movement is traditionally stronger
than diffusion, making it the primary mode of NP transport,
thus diminishing NP–cellular interactions and deposition.
While EGF-AuNPs displayed augmented deposition under
static conditions, the presence of fluid dynamics signifi-
cantly altered dosimetry, highlighting an area that is in
need of further investigation.
Through visualization of the nano-cellular interface, the
strong association of AuNPs and HaCaT cells was con-
firmed. Furthermore, AuNP internalization through endo-
cytosis was confirmed via TEM imaging. Flow-induced
modulations to cell morphology were observed, with sig-
nificant actin elongation in the direction of flow, in
agreement with the application of low levels of shear stress
(Breitner et al. 2015). In addition to altering the mode of
NP transport, altered cellular morphology will likely
impeded AuNP association and internalization through
disruption of the surface membrane. We believe that the
observed drop in deposition under dynamic flow arises
from the combination of modified modes of biotransport
and reconfiguration of the HaCaT membrane structure.
Fig. 7 Using a combination of
fluorescence and dark-field
microscopy, the nano-cellular
interface was visualized for
(a) AuNPs and (b) EGF-AuNPs
under static conditions and
(c) AuNPs and (d) EGF-AuNPs
under dynamic flow. In addition
to verifying the strong
interactions between NPs and
their surrounding environment,
these images identified that
dynamic flow altered HaCaT
morphology
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Taken together, this highlights the possibility of improving
NP deposition through targeted design of the protein
corona; however, to make this change effective it must
overcome physiological challenges, such as fluid dynamics.
Conclusion
Colloidal AuNPs hold tremendous potential to progress
current technologies in the biomedical sector, but are cur-
rently limited by dosimetry capabilities. This study sought
to explore if the rate of AuNP deposition and interactions
in an HaCaT cell model could be improved through the
targeted design of an EGF protein corona prior to biolog-
ical exposure. Our results demonstrated that it was possible
to generate an initial protein–NP complex and that these
AuNPs displayed modulated characteristics from stock
AuNPs, including greater particle stability and altered
corona composition. These observed changes to AuNP
physicochemical characteristics resulted in an improved
deposition efficiency and altered nano-cellular interface,
under static conditions. However, the introduction of
dynamic flow altered AuNP transport mechanisms, thereby
decreasing deposition and negating the previously seen
gains by EGF-AuNPs. Therefore, this proof-of-concept
work successfully demonstrated the plausibility and
potential of utilizing the protein corona as a means to
design and influence NP dosimetry; potentially improving
effectiveness of AuNP-based biomedical applications.
However, to effectively implement these modification in a
physiological environment, much work remains to better
understand and account for critical biological variables,
such as dynamic flow.
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